Medigene AG (MDG1) - Cash Flow Conversion Efficiency

Latest as of June 2024: -0.180x

Based on the latest financial reports, Medigene AG (MDG1) has a cash flow conversion efficiency ratio of -0.180x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.54 Million ≈ $-4.14 Million USD) by net assets (€19.66 Million ≈ $22.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medigene AG defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Medigene AG - Cash Flow Conversion Efficiency Trend (2006–2023)

This chart illustrates how Medigene AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medigene AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medigene AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PALATIN TECHS DL-01 F:PTN	N/A
Mantex AB ST:MANTEX	-1.685x
Diadrom Holding AB ST:DIAH	0.021x
CardioComm Solutions Inc. V:EKG	0.215x
Heritage Distilling Holding Company, Inc. NASDAQ:IPST	-0.076x
Reliance Global Group, Inc. NASDAQ:EZRA	-0.077x
Plantarc Bio Ltd TA:PLNT	-0.235x
Savannah Resources Plc LSE:SAV	-0.033x

Annual Cash Flow Conversion Efficiency for Medigene AG (2006–2023)

The table below shows the annual cash flow conversion efficiency of Medigene AG from 2006 to 2023. For the full company profile with market capitalisation and key ratios, see MDG1 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	€21.07 Million ≈ $24.63 Million	€-15.12 Million ≈ $-17.68 Million	-0.718x	-321.90%
2022-12-31	€37.03 Million ≈ $43.29 Million	€11.98 Million ≈ $14.00 Million	0.323x	+234.79%
2021-12-31	€44.82 Million ≈ $52.39 Million	€-10.75 Million ≈ $-12.57 Million	-0.240x	+48.54%
2020-12-31	€53.15 Million ≈ $62.14 Million	€-24.79 Million ≈ $-28.98 Million	-0.466x	-132.33%
2019-12-31	€81.82 Million ≈ $95.66 Million	€-16.42 Million ≈ $-19.20 Million	-0.201x	-112.60%
2018-12-31	€107.42 Million ≈ $125.59 Million	€-10.14 Million ≈ $-11.86 Million	-0.094x	+60.98%
2017-12-31	€86.17 Million ≈ $100.74 Million	€-20.85 Million ≈ $-24.37 Million	-0.242x	-406.02%
2016-12-31	€78.59 Million ≈ $91.88 Million	€-3.76 Million ≈ $-4.39 Million	-0.048x	+59.43%
2015-12-31	€89.99 Million ≈ $105.21 Million	€-10.61 Million ≈ $-12.40 Million	-0.118x	+33.95%
2014-12-31	€49.07 Million ≈ $57.37 Million	€-8.76 Million ≈ $-10.24 Million	-0.178x	+47.14%
2013-12-31	€36.28 Million ≈ $42.41 Million	€-12.25 Million ≈ $-14.32 Million	-0.338x	-129.38%
2012-12-31	€44.22 Million ≈ $51.69 Million	€-6.51 Million ≈ $-7.61 Million	-0.147x	-202.77%
2011-12-31	€47.93 Million ≈ $56.04 Million	€6.86 Million ≈ $8.02 Million	0.143x	+151.20%
2010-12-31	€40.80 Million ≈ $47.70 Million	€-11.41 Million ≈ $-13.34 Million	-0.280x	+23.34%
2009-12-31	€51.87 Million ≈ $60.64 Million	€-18.93 Million ≈ $-22.13 Million	-0.365x	+13.45%
2008-12-31	€64.91 Million ≈ $75.88 Million	€-27.36 Million ≈ $-31.99 Million	-0.422x	-35.63%
2007-12-31	€103.09 Million ≈ $120.53 Million	€-32.04 Million ≈ $-37.46 Million	-0.311x	-2564.08%
2006-12-31	€108.51 Million ≈ $126.86 Million	€-1.27 Million ≈ $-1.48 Million	-0.012x	--

About Medigene AG

XETRA:MDG1 Germany Biotechnology

Market Cap

$2.30 Million

€1.97 Million EUR

Market Cap Rank

#29984 Global

#2622 in Germany

Share Price

€0.13

Change (1 day)

+0.00%

52-Week Range

€0.13 - €0.13

All Time High

€36.05